Top stock pick for 2021 $ODT.
First recommended buy price ~$15.
My case for $ODT :
Odonate Therapeutics - a chemotherapy pill with better profile than uncomfortable infused Taxanes.
*Experts that attended the recent investor day believe the released data supports FDA approval https://twitter.com/zecontrarian7/status/1313163221247954944

*Especially encouraging was Dr. Schwartzberg enthusiasm as he is the medical director/ CMO of West Cancer Center, one of the largest oncology networks and drug purchasers in the country.
*Recent investor day data supports FDA approval and a TAM of $650MM.

*Kevin tang is a shrewd hedge fund manager with 20 years experience, he has never “blown up”, this is important because ->
*Tang capital, his hedge fund holds 41% of $ODT and he is buying more in the market in recent days.
*Kevin Tang has also been personally buying the stock.

*Boxer Capital, one of the top biotech hedge funds, have been loading up on the shares as well.
*Boxer Capital CIO and founder, Aaron Davis has also been personally buying the shares and gave $ODT as his personal top pick during the recent Sohn Conference..>

where hedge fund managers put forth their best ideas.
*The stock crashed from $40 to $15 on an aggressive stock offering, top hedge funds picked all they could from that offering which should give cash leeway for the foreseeable future. HAPPY NEW YEAR to all!

My earlier followers will remember I recommended this stock at ~$15 before, it reached ~$40 a few months later. Fortunately I recommended selling before the equity offering, unfortunately it was well below the peak.

Aaron Davis, Boxer Capital pitching $ODT as his best investment idea at Sohn Confrence. Minutes 15-18 in the video below.